Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score.
de Winter MA, Dorresteijn JAN, Ageno W, Ay C, Beyer-Westendorf J, Coppens M, Klok FA, Moustafa F, Riva N, Ruiz Artacho PC, Vanassche T, Nijkeuter M. de Winter MA, et al. Among authors: dorresteijn jan. Thromb Haemost. 2022 May;122(5):818-829. doi: 10.1055/s-0041-1735251. Epub 2021 Sep 20. Thromb Haemost. 2022. PMID: 34544170 Clinical Trial.
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease.
Burger PM, Dorresteijn JAN, Fiolet ATL, Koudstaal S, Eikelboom JW, Nidorf SM, Thompson PL, Cornel JH, Budgeon CA, Westendorp ICD, Beelen DPW, Martens FMAC, Steg PG, Asselbergs FW, Cramer MJ, Teraa M, Bhatt DL, Visseren FLJ, Mosterd A; LoDoCo2 Trial Investigators; UCC-SMART Study Group; REACH Registry Investigators. Burger PM, et al. Among authors: dorresteijn jan. Eur J Prev Cardiol. 2023 Dec 21;30(18):1950-1962. doi: 10.1093/eurjpc/zwad221. Eur J Prev Cardiol. 2023. PMID: 37409348
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score.
de Winter MA, Büller HR, Carrier M, Cohen AT, Hansen JB, Kaasjager KAH, Kakkar AK, Middeldorp S, Raskob GE, Sørensen HT, Visseren FLJ, Wells PS, Dorresteijn JAN, Nijkeuter M; VTE-PREDICT study group. de Winter MA, et al. Among authors: dorresteijn jan. Eur Heart J. 2023 Apr 7;44(14):1231-1244. doi: 10.1093/eurheartj/ehac776. Eur Heart J. 2023. PMID: 36648242 Free PMC article.
Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis.
de Winter MA, Uijl A, Büller HR, Carrier M, Cohen AT, Hansen JB, Kaasjager KHAH, Kakkar AK, Middeldorp S, Raskob GE, Sørensen HT, Wells PS, Nijkeuter M, Dorresteijn JAN. de Winter MA, et al. Among authors: dorresteijn jan. J Thromb Haemost. 2023 Mar;21(3):573-585. doi: 10.1016/j.jtha.2022.11.013. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696208 Free article.
Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial.
de Vries TI, Eikelboom JW, Bosch J, Westerink J, Dorresteijn JAN, Alings M, Dyal L, Berkowitz SD, van der Graaf Y, Fox KAA, Visseren FLJ. de Vries TI, et al. Among authors: dorresteijn jan. Eur Heart J. 2019 Dec 7;40(46):3771-3778a. doi: 10.1093/eurheartj/ehz404. Eur Heart J. 2019. PMID: 31504399 Clinical Trial.
SPRINT trial: It's not just the blood pressure!
Berkelmans GF, Visseren FL, Jaspers NE, Spiering W, van der Graaf Y, Dorresteijn JA. Berkelmans GF, et al. Eur J Prev Cardiol. 2017 Sep;24(14):1482-1484. doi: 10.1177/2047487317723213. Epub 2017 Jul 27. Eur J Prev Cardiol. 2017. PMID: 28749177 Clinical Trial.
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
Hageman SHJ, McKay AJ, Ueda P, Gunn LH, Jernberg T, Hagström E, Bhatt DL, Steg PG, Läll K, Mägi R, Gynnild MN, Ellekjær H, Saltvedt I, Tuñón J, Mahíllo I, Aceña Á, Kaminski K, Chlabicz M, Sawicka E, Tillman T, McEvoy JW, Di Angelantonio E, Graham I, De Bacquer D, Ray KK, Dorresteijn JAN, Visseren FLJ. Hageman SHJ, et al. Among authors: dorresteijn jan. Eur Heart J. 2022 May 7;43(18):1715-1727. doi: 10.1093/eurheartj/ehac056. Eur Heart J. 2022. PMID: 35165703 Free PMC article.
84 results